Bonesupport Holding AB (publ)

OVERVALUED2B4.F · FSX · Healthcare
2B4.F·FSX·Healthcare
OVERVALUED
Bonesupport Holding AB (publ)
31.5%downside
MARKET PRICE
$20.92
FAIR PRICE
$14.34
MARGIN
$6.58
UNDERVALUEDFAIROVERVALUED
P/E RATIO
133.7x
DIV. YIELD
N/A
ROE
17.9%
MARKET CAP
$15B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

31.5%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$20.92

FAIR PRICE

$14.34

MARGIN

$6.58

UNDERVALUEDFAIROVERVALUED

P/E Ratio

133.7x

What is P/E? →

Div. Yield

N/A

ROE

17.9%

Strong

Market Cap

$15B

Large-cap

NOW AVAILABLE

Get notified when 2B4.F's fair price changes

Push notifications when 2B4.F's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

6.2/ 10

Low debt levels and consistent growth trajectory, but volatile earnings pattern and expensive valuation relative to fundamentals.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$11.47CONSERVATIVE ENTRY
$14.34FAIR PRICE
$20.92MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$11.47

Fair price × 0.80

DISTANCE

45.2%

Price to entry level

At the current price of $20.92, 2B4.F trades 45.2% above the conservative entry level of $11.47. This entry level represents a 20% margin of safety below the calculated fair price of $14.34 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate 2B4.F's fair price

Bonesupport Holding AB (publ)'s fair price of $14.34 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $20.92, 2B4.F trades 31.5% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting 2B4.F's risk profile.

RELATIVE · 30%

Comparing 2B4.F's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for 2B4.F, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate 2B4.F's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for 2B4.F.

Explore on Bulios

FAQ

What is the fair price of 2B4.F?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Bonesupport Holding AB (publ) is $14.34. At the current market price of $20.92, 2B4.F trades 31.5% above its calculated fair value.

Is 2B4.F overvalued or undervalued?+

Bonesupport Holding AB (publ) is currently overvalued based on our valuation model. The stock trades at $20.92, which is 31.5% above the fair price of $14.34. The P/E ratio of 133.7x is a key metric in the valuation.

What is the margin of safety for 2B4.F?+

With a 20% margin of safety applied to the fair price of $14.34, the conservative entry level for 2B4.F is $11.47. At the current market price of $20.92, the stock trades 45.2% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is 2B4.F's fair price updated?+

We update fair price calculations for 2B4.F daily after market close. The current fair price of $14.34 incorporates the latest market data and sector multiples.

What factors affect 2B4.F's fair price calculation?+

2B4.F's fair price of $14.34 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 133.7x, ROE of 17.9%.

Is 2B4.F a good buy right now?+

At $20.92, 2B4.F trades 31.5% above our fair value estimate of $14.34. The stock is currently overvalued. ROE stands at 17.9% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does 2B4.F pay dividends?+

2B4.F does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.